Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Aquestive Therapeutics, Inc. Common Stock

AQST Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of AQST by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
AQST Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
AQST Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AQST Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in AQST holdings by institutional investors

Quarterly net insider trading by AQST's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for AQST

7 former government officials from 4 congressional offices at 2 lobbying firms have lobbied for AQST, most recently Jan 20, 2026.

  • Rodney P. Frelinghuysen
    Edward Krenik House Assoc. Admin. Cong. Affairs, EPA (2001-03); Leg.Director,Rep. Frelinghuysen (1994-01); Leg. Asst/Assoc.Staff, Rep.Dean Gallo (1989-94); Leg. Asst. Sen. Durenberger(1987-89) Formerly with Rodney P. Frelinghuysen · BRACEWELL LLP · Jan 20, 2026
  • Charles E. Schumer
    Jason Abel Senate New Chief Counsel, Senate Rules Cmtee; Counsel, Senator Schumer Formerly with Charles E. Schumer · STEPTOE LLP · Apr 17, 2025
  • Matthew Flynn House New Dep Asst Sec Def (DOD); Counselor, Land & Minerals Mgmt (DOI); Dep Asst to the Pres & Acting WH Cabinet Sec., Dep Cabinet Sec., Special Asst to the Pres, Sr. Dir. for Cabinet Affairs, (EOP); Sr Advisor (State); LC/Dep Health Counsel, Intern (House Formerly Dep Asst Sec Def (DOD); Counselor, Land & Minerals Mgmt (DOI); Dep Asst to the P · STEPTOE LLP · Apr 17, 2025
  • Michele Nellenbach Senate New Sr. Professional Staff Member, Senate EPW Formerly Sr. Professional Staff Member, Senate EPW · STEPTOE LLP · Apr 17, 2025
  • Darryl Nirenberg Other New PSSenAgCom83-87; CDSDSenFRCom87-91; CSSenHelms91-95 Formerly PSSenAgCom83-87; CDSDSenFRCom87-91; CSSenHelms91-95 · STEPTOE LLP · Jul 20, 2021
  • Sue Wilkins Myrick
    Lisa Waltzman House New Policy Director, Representative Sue Myrick (2002-2005) Formerly with Sue Wilkins Myrick · STEPTOE LLP · Jun 27, 2019
  • James Barnette House New Gen Counsel, House Energy & Commerce Comm (1995-2005; 2011-2012) Formerly Gen Counsel, House Energy & Commerce Comm (1995-2005; 2011-2012) · STEPTOE LLP · Jun 27, 2019

AQST Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

AQST Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
AQST Income Statement
AQST Balance Sheet
AQST Cash Flow
U.S. Patents

New AQST patent grants

  • Patent Title: Linear polysaccharide based film products May. 12, 2026
  • Patent Title: Oral and nasal compositions and methods of treatment Nov. 11, 2025
  • Patent Title: Enhanced delivery epinephrine and prodrug compositions Oct. 07, 2025
  • Patent Title: Enhanced delivery epinephrine compositions Sep. 30, 2025
  • Patent Title: Oral film compositions and dosage forms having precise active dissolution profiles Sep. 02, 2025
  • Patent Title: System and method for making personalized individual unit doses containing pharmaceutical actives May. 27, 2025
  • Patent Title: Oral film compositions and dosage forms having precise active dissolution profiles May. 06, 2025
  • Patent Title: System and method for making personalized individual unit doses containing pharmaceutical actives Dec. 24, 2024
  • Patent Title: Enhanced delivery epinephrine compositions Jul. 02, 2024
  • Patent Title: System and method for making personalized individual unit doses containing pharmaceutical actives Nov. 07, 2023
  • Patent Title: Oral film compositions and dosage forms having precise active dissolution profiles Jan. 03, 2023
  • Patent Title: Pharmaceutical compositions with enhanced permeation Mar. 15, 2022
  • Patent Title: Process for manufacturing a resulting pharmaceutical film Dec. 28, 2021
  • Patent Title: Enhanced delivery epinephrine compositions Dec. 07, 2021
  • Patent Title: Enhanced delivery epinephrine compositions Nov. 02, 2021
  • Patent Title: Dual lane coating Sep. 28, 2021
  • Patent Title: Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions Aug. 03, 2021
  • Patent Title: Reduction in stress cracking of films Mar. 16, 2021
  • Patent Title: Manufacturing of small film strips Mar. 09, 2021
  • Patent Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom Jan. 12, 2021
  • Patent Title: Sublingual and buccal film compositions Nov. 03, 2020
  • Patent Title: Process for manufacturing a resulting pharmaceutical film Aug. 04, 2020
  • Patent Title: Reduction in stress cracking of films Nov. 05, 2019
  • Patent Title: Manufacturing of small film strips Apr. 30, 2019
  • Patent Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom Oct. 30, 2018
  • Patent Title: Sublingual and buccal film compositions Jul. 31, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to AQST from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
AQST News

Recent insights relating to AQST

CNBC Recommendations

Recent picks made for AQST stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AQST

AQST Analyst Ratings

AQST Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
AQST Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $AQST stock a Buy, Sell, or Hold?

  • What is the price target for $AQST stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

AQST Top Shareholders
Shareholder
Shares Held
AQST Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $AQST stock?

  • Who owns the most shares of $AQST stock?

  • What funds own $AQST stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AQST Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AQST Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About AQST

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

  • Address Warren, NJ
  • Market Cap 589.9 million
  • Employees 147
  • Industrial Classification Pharmaceutical Preparations

Aquestive Therapeutics, Inc. Common Stock (AQST) Historical Stock Prices

Aquestive Therapeutics, Inc. Common Stock (AQST) closed at $4.70 on September 23, 2026. Over the past year its adjusted close ranged from $2.95 to $7.49. Daily prices go back to July 25, 2018, 2,052 trading days in all.

  • 1 month-2.08%
  • 3 months-5.81%
  • Year to date-27.24%
  • 1 year-9.62%
  • 3 years+197.47%
  • 5 years+8.55%
  • Max-70.72%
See every congressional and insider trade on the AQST price chart

Quiver Premium charts AQST's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 4.92 5.00 4.70 4.70 4.70 1,951,994
Sep 22, 2026 4.81 5.11 4.78 4.95 4.95 2,481,884
Sep 21, 2026 4.65 4.83 4.56 4.78 4.78 2,455,976
Sep 18, 2026 4.65 4.65 4.51 4.61 4.61 3,509,333
Sep 17, 2026 5.00 5.00 4.62 4.66 4.66 2,530,112
Sep 16, 2026 4.84 4.95 4.74 4.82 4.82 1,351,944
Sep 15, 2026 4.82 4.90 4.76 4.81 4.81 1,607,316
Sep 14, 2026 4.70 4.90 4.66 4.88 4.88 2,491,770
Sep 11, 2026 4.99 5.13 4.74 4.78 4.78 4,159,293
Sep 10, 2026 5.13 5.30 4.92 4.99 4.99 3,284,182
Sep 9, 2026 5.22 5.25 5.07 5.15 5.15 1,884,905
Sep 8, 2026 5.39 5.42 5.16 5.21 5.21 1,984,961
Sep 4, 2026 5.32 5.49 5.29 5.34 5.34 2,117,771
Sep 3, 2026 5.40 5.44 5.22 5.35 5.35 1,832,179
Sep 2, 2026 5.25 5.39 5.25 5.38 5.38 1,814,473
Sep 1, 2026 5.15 5.35 5.09 5.24 5.24 2,168,960
Aug 31, 2026 4.97 5.12 4.91 5.11 5.11 1,908,012
Aug 28, 2026 5.11 5.18 4.97 5.02 5.02 2,517,467
Aug 27, 2026 5.39 5.39 5.12 5.16 5.16 3,663,314
Aug 26, 2026 5.08 5.41 5.01 5.39 5.39 3,412,030
Aug 25, 2026 4.77 5.12 4.72 5.08 5.08 3,668,722
Aug 24, 2026 4.67 4.82 4.56 4.80 4.80 2,610,398
Aug 21, 2026 4.54 4.72 4.52 4.66 4.66 2,015,907
Aug 20, 2026 4.61 4.64 4.39 4.50 4.50 2,668,133
Aug 19, 2026 4.31 4.75 4.31 4.59 4.59 8,415,711
Aug 18, 2026 4.27 4.39 4.25 4.32 4.32 5,455,979
Aug 17, 2026 4.22 4.35 4.20 4.29 4.29 3,338,666
Aug 14, 2026 4.20 4.28 4.01 4.25 4.25 4,350,128
Aug 13, 2026 4.25 4.39 4.14 4.25 4.25 3,745,394
Aug 12, 2026 4.27 4.44 4.19 4.23 4.23 9,116,267
Aug 11, 2026 4.30 4.69 4.24 4.41 4.41 6,495,034
Aug 10, 2026 4.35 4.63 4.26 4.29 4.29 7,295,514
Aug 7, 2026 3.95 4.04 3.87 3.94 3.94 1,860,430
Aug 6, 2026 3.76 3.92 3.76 3.92 3.92 1,536,412
Aug 5, 2026 3.72 3.84 3.71 3.75 3.75 1,466,033
Aug 4, 2026 3.85 3.87 3.65 3.74 3.74 2,691,743
Aug 3, 2026 3.70 3.82 3.67 3.79 3.79 2,381,422
Jul 31, 2026 3.75 3.78 3.60 3.69 3.69 1,785,710
Jul 30, 2026 3.63 3.74 3.60 3.72 3.72 1,446,648
Jul 29, 2026 3.76 3.78 3.56 3.60 3.60 2,584,958
Jul 28, 2026 3.74 3.78 3.62 3.76 3.76 2,820,715
Jul 27, 2026 3.64 3.86 3.61 3.73 3.73 1,814,779
Jul 24, 2026 3.89 3.89 3.64 3.68 3.68 2,881,478
Jul 23, 2026 3.90 3.92 3.76 3.77 3.77 2,015,861
Jul 22, 2026 4.04 4.07 3.92 3.94 3.94 1,707,558
Jul 21, 2026 3.94 4.08 3.91 4.04 4.04 1,797,137
Jul 20, 2026 4.12 4.18 3.94 3.94 3.94 1,434,370
Jul 17, 2026 3.89 4.16 3.81 4.12 4.12 2,356,421
Jul 16, 2026 3.92 4.08 3.86 3.94 3.94 1,921,636
Jul 15, 2026 4.04 4.04 3.88 3.95 3.95 1,887,165
Jul 14, 2026 4.02 4.11 3.98 4.04 4.04 901,361
Jul 13, 2026 4.09 4.12 3.99 4.06 4.06 1,625,292
Jul 10, 2026 4.25 4.25 4.00 4.12 4.12 3,054,111
Jul 9, 2026 4.32 4.36 4.24 4.24 4.24 917,144
Jul 8, 2026 4.26 4.34 4.24 4.31 4.31 1,217,295
Jul 7, 2026 4.32 4.38 4.24 4.33 4.33 1,353,872
Jul 6, 2026 4.19 4.29 4.17 4.24 4.24 1,468,623
Jul 2, 2026 4.23 4.36 4.14 4.18 4.18 1,732,804
Jul 1, 2026 4.21 4.29 4.18 4.24 4.24 1,262,894
Jun 30, 2026 4.17 4.24 4.13 4.16 4.16 1,489,557
Jun 29, 2026 4.36 4.36 4.10 4.16 4.16 3,293,950
Jun 26, 2026 4.46 4.47 4.22 4.39 4.39 7,384,747
Jun 25, 2026 4.90 4.90 4.16 4.46 4.46 5,171,645
Jun 24, 2026 5.05 5.18 4.92 4.99 4.99 2,226,196
Jun 23, 2026 4.71 5.11 4.71 5.03 5.03 2,988,647
Jun 22, 2026 4.71 4.91 4.68 4.72 4.72 1,937,034
Jun 18, 2026 4.49 4.74 4.45 4.71 4.71 3,138,143
Jun 17, 2026 4.26 4.48 4.25 4.43 4.43 1,977,231
Jun 16, 2026 4.20 4.30 4.20 4.26 4.26 1,054,290
Jun 15, 2026 4.21 4.26 4.12 4.22 4.22 1,309,618
Jun 12, 2026 4.20 4.30 4.17 4.17 4.17 1,223,124
Jun 11, 2026 4.01 4.25 3.96 4.21 4.21 1,890,748
Jun 10, 2026 3.95 4.05 3.92 3.99 3.99 1,588,511
Jun 9, 2026 3.94 4.03 3.87 3.99 3.99 1,395,356
Jun 8, 2026 4.00 4.02 3.85 3.91 3.91 1,539,363
Jun 5, 2026 4.14 4.16 3.92 3.93 3.93 1,234,997
Jun 4, 2026 4.05 4.22 4.05 4.14 4.14 1,937,749
Jun 3, 2026 3.90 4.04 3.85 4.03 4.03 1,698,408
Jun 2, 2026 3.98 3.98 3.87 3.93 3.93 1,972,394
Jun 1, 2026 4.00 4.07 3.95 4.00 4.00 1,413,035
May 29, 2026 4.02 4.10 3.96 4.02 4.02 1,324,064
May 28, 2026 4.01 4.05 3.96 4.02 4.02 1,416,817
May 27, 2026 4.07 4.11 4.00 4.00 4.00 1,388,709
May 26, 2026 4.15 4.18 4.08 4.08 4.08 1,051,732
May 22, 2026 4.26 4.29 4.12 4.12 4.12 893,169
May 21, 2026 4.11 4.25 4.08 4.23 4.23 1,350,223
May 20, 2026 4.10 4.23 4.10 4.17 4.17 1,204,145
May 19, 2026 4.07 4.14 4.03 4.09 4.09 1,557,571
May 18, 2026 4.17 4.23 3.98 4.13 4.13 2,688,452
May 15, 2026 4.64 4.67 4.16 4.17 4.17 3,419,764
May 14, 2026 4.75 5.02 4.48 4.73 4.73 5,849,660
May 13, 2026 4.18 4.24 4.10 4.13 4.13 2,477,293
May 12, 2026 4.31 4.40 4.16 4.16 4.16 1,401,881
May 11, 2026 4.30 4.43 4.25 4.34 4.34 1,387,465
May 8, 2026 4.25 4.36 4.25 4.32 4.32 1,893,103
May 7, 2026 4.23 4.30 4.16 4.23 4.23 1,307,334
May 6, 2026 4.17 4.33 4.13 4.23 4.23 1,628,626
May 5, 2026 4.22 4.29 4.13 4.18 4.18 991,590
May 4, 2026 4.18 4.29 4.18 4.22 4.22 1,096,478
May 1, 2026 4.13 4.22 4.11 4.20 4.20 976,104
Apr 30, 2026 4.07 4.17 4.06 4.10 4.10 1,526,189
Apr 29, 2026 4.06 4.12 4.01 4.05 4.05 1,064,353
Apr 28, 2026 4.11 4.19 4.06 4.09 4.09 876,984
Apr 27, 2026 4.06 4.18 4.06 4.10 4.10 785,968
Apr 24, 2026 4.10 4.12 4.03 4.08 4.08 1,091,072
Apr 23, 2026 4.15 4.20 4.06 4.07 4.07 1,059,848
Apr 22, 2026 4.34 4.40 4.12 4.15 4.15 2,153,263
Apr 21, 2026 4.25 4.36 4.16 4.34 4.34 1,350,896
Apr 20, 2026 4.30 4.42 4.20 4.24 4.24 1,711,198
Apr 17, 2026 4.30 4.40 4.29 4.32 4.32 1,066,820
Apr 16, 2026 4.25 4.30 4.15 4.26 4.26 961,402
Apr 15, 2026 4.15 4.25 4.13 4.24 4.24 889,370
Apr 14, 2026 4.19 4.26 4.12 4.15 4.15 1,200,762
Apr 13, 2026 4.09 4.22 4.09 4.19 4.19 970,878
Apr 10, 2026 4.18 4.21 4.04 4.08 4.08 996,207
Apr 9, 2026 4.12 4.21 4.12 4.17 4.17 723,893
Apr 8, 2026 4.24 4.28 4.14 4.18 4.18 1,301,244
Apr 7, 2026 4.07 4.14 3.99 4.13 4.13 1,157,143
Apr 6, 2026 4.11 4.16 4.08 4.09 4.09 858,940
Apr 2, 2026 4.06 4.17 4.04 4.13 4.13 919,131
Apr 1, 2026 4.19 4.24 4.09 4.13 4.13 938,577
Mar 31, 2026 4.05 4.24 4.05 4.15 4.15 1,238,064
Mar 30, 2026 4.00 4.08 3.94 4.04 4.04 2,424,094
Mar 27, 2026 4.06 4.14 4.00 4.02 4.02 1,198,438
Mar 26, 2026 4.19 4.30 4.12 4.14 4.14 1,397,182
Mar 25, 2026 3.91 4.22 3.91 4.21 4.21 1,840,520
Mar 24, 2026 3.90 3.91 3.77 3.88 3.88 1,538,877
Mar 23, 2026 4.09 4.12 3.88 3.93 3.93 1,344,775
Mar 20, 2026 4.04 4.13 3.96 3.98 3.98 2,658,983
Mar 19, 2026 3.98 4.17 3.96 4.06 4.06 2,109,990
Mar 18, 2026 4.07 4.11 3.96 4.02 4.02 2,266,399
Mar 17, 2026 4.19 4.26 4.09 4.11 4.11 1,317,608
Mar 16, 2026 4.03 4.23 3.99 4.18 4.18 1,753,466
Mar 13, 2026 4.04 4.11 3.96 4.02 4.02 1,662,732
Mar 12, 2026 4.24 4.25 4.01 4.03 4.03 2,229,174
Mar 11, 2026 4.23 4.41 4.20 4.27 4.27 1,697,868
Mar 10, 2026 4.19 4.37 4.17 4.20 4.20 2,361,416
Mar 9, 2026 4.12 4.33 4.09 4.29 4.29 1,972,795
Mar 6, 2026 4.17 4.25 4.07 4.22 4.22 2,408,103
Mar 5, 2026 4.26 4.50 4.13 4.26 4.26 4,856,272
Mar 4, 2026 4.12 4.40 4.12 4.37 4.37 2,338,968
Mar 3, 2026 4.10 4.20 4.05 4.12 4.12 2,514,049
Mar 2, 2026 3.86 4.24 3.86 4.21 4.21 2,316,394
Feb 27, 2026 4.03 4.04 3.91 4.00 4.00 3,710,076
Feb 26, 2026 4.15 4.22 4.01 4.11 4.11 1,617,161
Feb 25, 2026 4.12 4.23 4.05 4.14 4.14 2,165,075
Feb 24, 2026 3.97 4.10 3.89 4.09 4.09 2,443,726
Feb 23, 2026 3.90 4.00 3.86 3.97 3.97 1,745,452
Feb 20, 2026 3.93 4.06 3.90 3.95 3.95 1,965,828
Feb 19, 2026 3.81 3.97 3.72 3.96 3.96 2,000,457
Feb 18, 2026 3.87 3.98 3.76 3.83 3.83 1,796,724
Feb 17, 2026 3.65 3.90 3.65 3.88 3.88 2,194,718
Feb 13, 2026 3.74 3.80 3.61 3.65 3.65 2,594,291
Feb 12, 2026 3.81 3.87 3.69 3.75 3.75 2,443,427
Feb 11, 2026 3.86 3.90 3.65 3.82 3.82 2,736,914
Feb 10, 2026 3.90 3.97 3.86 3.86 3.86 2,099,175
Feb 9, 2026 4.10 4.10 3.83 3.94 3.94 2,564,592
Feb 6, 2026 3.91 4.18 3.88 4.11 4.11 2,939,773
Feb 5, 2026 3.91 4.03 3.78 3.84 3.84 3,974,974
Feb 4, 2026 4.09 4.14 3.92 4.00 4.00 4,134,985
Feb 3, 2026 4.15 4.31 4.00 4.10 4.10 7,642,979
Feb 2, 2026 4.00 4.39 3.79 4.10 4.10 61,083,859
Jan 30, 2026 3.16 3.21 2.93 2.95 2.95 5,637,656
Jan 29, 2026 3.23 3.25 3.13 3.16 3.16 3,459,591
Jan 28, 2026 3.48 3.50 3.20 3.24 3.24 3,848,360
Jan 27, 2026 3.22 3.50 3.22 3.47 3.47 3,511,279
Jan 26, 2026 3.24 3.30 3.17 3.24 3.24 2,611,179
Jan 23, 2026 3.25 3.38 3.23 3.24 3.24 2,591,844
Jan 22, 2026 3.36 3.42 3.24 3.25 3.25 3,161,337
Jan 21, 2026 3.50 3.50 3.15 3.36 3.36 5,456,667
Jan 20, 2026 3.29 3.55 3.21 3.48 3.48 5,214,056
Jan 16, 2026 3.34 3.39 3.26 3.31 3.31 4,785,136
Jan 15, 2026 3.50 3.54 3.31 3.34 3.34 4,299,456
Jan 14, 2026 3.32 3.60 3.32 3.52 3.52 7,088,037
Jan 13, 2026 3.50 3.50 3.21 3.42 3.42 9,968,823
Jan 12, 2026 3.90 3.91 3.49 3.51 3.51 13,771,302
Jan 9, 2026 4.04 4.15 3.58 3.91 3.91 43,701,505
Jan 8, 2026 6.22 6.30 6.09 6.21 6.21 2,256,785
Jan 7, 2026 6.33 6.34 5.86 6.23 6.23 3,373,451
Jan 6, 2026 6.28 6.36 6.08 6.24 6.24 1,818,826
Jan 5, 2026 6.46 6.47 6.17 6.23 6.23 2,291,766
Jan 2, 2026 6.54 6.59 6.16 6.45 6.45 3,321,854
Dec 31, 2025 6.31 6.57 6.23 6.46 6.46 1,927,220
Dec 30, 2025 6.44 6.50 6.29 6.38 6.38 2,638,750
Dec 29, 2025 6.00 6.48 5.94 6.47 6.47 3,505,017
Dec 26, 2025 6.00 6.05 5.83 5.99 5.99 1,738,646
Dec 24, 2025 5.88 6.05 5.84 5.97 5.97 1,026,429
Dec 23, 2025 5.94 5.99 5.78 5.87 5.87 1,578,051
Dec 22, 2025 5.83 6.04 5.71 5.96 5.96 2,732,054
Dec 19, 2025 5.84 5.93 5.78 5.80 5.80 4,614,256
Dec 18, 2025 5.81 5.92 5.72 5.81 5.81 1,813,523
Dec 17, 2025 5.82 5.91 5.61 5.63 5.63 1,527,932
Dec 16, 2025 5.90 5.98 5.68 5.82 5.82 2,728,053
Dec 15, 2025 6.23 6.23 5.87 5.91 5.91 2,719,749
Dec 12, 2025 6.39 6.40 6.19 6.21 6.21 1,301,597
Dec 11, 2025 6.23 6.43 6.17 6.32 6.32 1,955,317
Dec 10, 2025 6.10 6.24 5.99 6.23 6.23 3,566,830
Dec 9, 2025 6.63 6.65 6.09 6.10 6.10 2,781,420
Dec 8, 2025 6.43 6.74 6.37 6.62 6.62 2,101,914
Dec 5, 2025 6.44 6.54 6.33 6.38 6.38 1,468,008
Dec 4, 2025 6.20 6.55 6.13 6.44 6.44 2,276,626
Dec 3, 2025 5.98 6.21 5.90 6.15 6.15 2,135,788
Dec 2, 2025 6.22 6.34 5.92 5.93 5.93 1,957,502
Dec 1, 2025 6.10 6.26 6.01 6.20 6.20 1,929,379
Nov 28, 2025 6.28 6.40 6.18 6.19 6.19 1,670,220
Nov 26, 2025 6.15 6.29 5.88 6.22 6.22 3,331,167
Nov 25, 2025 5.80 6.12 5.73 6.09 6.09 2,905,071
Nov 24, 2025 5.80 5.94 5.76 5.78 5.78 3,473,981
Nov 21, 2025 5.54 5.79 5.53 5.72 5.72 2,015,102
Nov 20, 2025 5.84 6.17 5.54 5.62 5.62 2,744,486
Nov 19, 2025 5.95 6.15 5.64 5.83 5.83 3,035,726
Nov 18, 2025 5.77 5.95 5.68 5.91 5.91 2,056,129
Nov 17, 2025 5.39 5.83 5.35 5.82 5.82 3,925,512
Nov 14, 2025 5.24 5.51 5.21 5.39 5.39 2,543,740
Nov 13, 2025 5.50 5.60 5.29 5.30 5.30 3,506,331
Nov 12, 2025 5.71 5.78 5.50 5.58 5.58 3,121,798
Nov 11, 2025 5.49 5.75 5.44 5.69 5.69 2,855,210
Nov 10, 2025 6.15 6.17 5.44 5.58 5.58 4,255,325
Nov 7, 2025 6.41 6.41 5.79 6.04 6.04 2,822,282
Nov 6, 2025 6.48 6.85 6.06 6.13 6.13 3,896,336
Nov 5, 2025 6.08 6.19 5.84 6.00 6.00 3,321,961
Nov 4, 2025 6.11 6.46 6.08 6.08 6.08 2,391,583
Nov 3, 2025 6.78 6.79 6.16 6.49 6.49 4,164,377
Oct 31, 2025 6.68 6.87 6.58 6.82 6.82 1,747,844
Oct 30, 2025 6.53 6.92 6.53 6.66 6.66 2,365,909
Oct 29, 2025 6.69 6.72 6.39 6.48 6.48 2,996,328
Oct 28, 2025 6.94 7.05 6.70 6.72 6.72 1,948,705
Oct 27, 2025 6.87 7.08 6.82 7.00 7.00 2,022,866
Oct 24, 2025 7.14 7.18 6.83 6.84 6.84 2,427,314
Oct 23, 2025 6.84 7.05 6.81 7.01 7.01 1,849,742
Oct 22, 2025 6.95 6.96 6.63 6.84 6.84 3,417,169
Oct 21, 2025 7.36 7.44 6.93 7.04 7.04 2,932,590
Oct 20, 2025 7.20 7.55 7.17 7.49 7.49 3,213,029
Oct 17, 2025 6.91 7.23 6.78 7.08 7.08 3,330,854
Oct 16, 2025 7.49 7.50 7.00 7.01 7.01 4,523,008
Oct 15, 2025 7.00 7.51 6.89 7.34 7.34 4,869,256
Oct 14, 2025 6.67 6.97 6.51 6.88 6.88 2,818,330
Oct 13, 2025 6.60 6.82 6.45 6.66 6.66 2,841,864
Oct 10, 2025 6.69 6.73 6.39 6.54 6.54 3,415,236
Oct 9, 2025 6.34 6.87 6.33 6.69 6.69 5,922,561
Oct 8, 2025 6.04 6.40 5.91 6.20 6.20 4,525,854
Oct 7, 2025 5.99 6.08 5.79 5.97 5.97 2,141,142
Oct 6, 2025 5.84 5.98 5.78 5.97 5.97 1,967,844
Oct 3, 2025 5.77 5.93 5.68 5.80 5.80 2,164,359
Oct 2, 2025 5.90 5.93 5.61 5.77 5.77 2,395,569
Oct 1, 2025 5.59 5.93 5.53 5.88 5.88 2,637,549
Sep 30, 2025 5.60 5.69 5.47 5.59 5.59 2,679,796
Sep 29, 2025 6.03 6.14 5.64 5.65 5.65 3,840,638
Sep 26, 2025 5.89 6.43 5.82 5.99 5.99 12,135,272
Sep 25, 2025 5.37 5.51 5.20 5.26 5.26 3,608,146
Sep 24, 2025 5.23 5.44 5.20 5.42 5.42 1,911,466
Sep 23, 2025 5.17 5.65 5.08 5.20 5.20 4,468,463

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Aquestive Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at AQST, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation